HIV-1 RNA Combo 1
HIV Combo Test Overview
The HIV combo test, also known as the HIV Ag/Ab combo test, is a sophisticated diagnostic tool designed to detect both the antibodies and the p24 antigen of the Human Immunodeficiency Virus (HIV). This test plays a crucial role in the early detection and diagnosis of HIV-1 and HIV-2 infections, as it can identify the presence of the virus even before the body has developed antibodies.
By employing advanced techniques such as chemiluminescent microparticle immunoassay (CMIA) or enzyme-linked immunosorbent assay (ELISA), the HIV Combo Test accurately detects the presence of HIV p24 antigen and antibodies to HIV-1 and HIV-2 in human serum, plasma, or whole blood.
The HIV combo test serves as a vital tool for healthcare professionals in their efforts to prevent the transmission of HIV through blood, blood components, cells, tissues, and organs. Its ability to detect the virus in the early stages of infection makes it an invaluable asset in the fight against the spread of HIV.
HIV-1 RNA, a vital component of the human immunodeficiency virus type 1, is its genetic material. The HIV-1 RNA Combo 1 diagnostic test employs a comprehensive approach, integrating both Flow Cytometry and Real-Time Polymerase Chain Reaction (RT-PCR) techniques to detect and quantify human immunodeficiency virus type 1 (HIV-1) RNA in a patient's blood sample. This combination of methodologies enhances the accuracy and reliability of HIV diagnosis and monitoring. Flow Cytometry allows for the enumeration of CD4+ T lymphocytes, a key component of the immune system targeted by HIV, providing valuable information about the immune status of the individual. Concurrently, Real-Time PCR amplifies and quantifies HIV-1 RNA, offering a sensitive and specific measure of viral load. By combining these two diagnostic approaches, healthcare professionals can gain comprehensive insights into the progression of HIV infection, tailor treatment strategies, and monitor the effectiveness of antiretroviral therapy. The HIV-1 RNA Combo 1 test serves as a powerful tool in the ongoing management and care of individuals living with HIV, facilitating timely interventions to optimize health outcomes.
Reasons for Undergoing the HIV Combo Test
The HIV combo test is essential for several reasons:
- Early Detection: It identifies HIV earlier than antibody-only tests by detecting the p24 antigen, enabling timely intervention.
- Screening Tool: Used to prevent HIV transmission through blood, tissues, or organs
- Diagnostic Aid: Helps diagnose HIV-1 and HIV-2, including acute infections
- Risk Assessment: Recommended for those with recent high-risk exposure, supporting early treatment and prevention efforts.
List of Parameters Considered During the HIV Combo Test
The HIV combo test measures the following key parameters to determine the presence of HIV infection:
- HIV p24 Antigen: This protein is a part of the virus itself and its presence indicates an active HIV infection, particularly in the early stages before the body has produced antibodies.
- Antibodies to HIV-1 and HIV-2: These are proteins produced by the immune system in response to the presence of the HIV virus.
HIV Combo Test Preparation
Proper preparation is essential to ensure accurate results from the HIV combo test that typically requires a blood sample, which can be collected through venipuncture (venous blood) or fingerstick (capillary whole blood). It is crucial to follow proper sample collection techniques to avoid contamination and ensure the integrity of the sample. Fasting is not required for the HIV combo test.
HIV Combo Test Results & Interpretation
The results of the HIV combo test provide valuable information about an individual's HIV status. The interpretation of the results is as follows:
- Reactive Results: If the test is reactive (positive), it indicates the presence of either the HIV p24 antigen or antibodies to HIV-1 and/or HIV-2. However, a reactive result must be confirmed with additional, more specific tests such as immunoblots, antigen tests, or HIV nucleic acid tests to rule out false positives. A confirmed positive result indicates an active HIV infection and appropriate medical care and support should be sought.
- Non-Reactive Results: A non-reactive (negative) result indicates that no HIV p24 antigen or antibodies were detected in the sample. However, it is important to consider the window period (the time between exposure to the virus and when the test can detect it) and the individual's risk factors.
Home Collection for HIV Combo Test
Metropolis Healthcare offers a convenient home sample collection service for the HIV combo test, ensuring comfort and safety for individuals who prefer not to visit a clinic. A trained phlebotomist will come to your doorstep to collect the required blood sample, maintaining the highest standards of sample handling and testing accuracy. This service ensures that you receive timely and reliable results without compromising the quality of the diagnostic process.
By opting for Metropolis Healthcare's home collection option, you can take advantage of their commitment to making healthcare accessible and their drive to provide quality diagnostic solutions conveniently at home.
HIV-1 RNA Combo 1 Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the HIV-1 RNA Combo 1 with a clear pricing structure.
The HIV-1 RNA Combo 1 Price in Mumbai is âı 7,800 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
Flow Cytometry allows for the enumeration of CD4+ T lymphocytes while Real-Time PCR amplifies and quantifies HIV-1 RNA.
HIV-1 RNA Combo 1 is done for several reasons, including:
- Monitoring the effectiveness of HIV treatment
- Assessing disease progression
- Evaluating viral load and response to antiretroviral therapy
- Determining when to start or change treatment
- Testing newborns born to mothers with HIV
HIV-1 RNA Combo 1 is recommended in the following cases:
- Confirming an HIV diagnosis
- Monitoring individuals with known HIV infection
- Evaluating pregnant women with HIV
- Assessing newborns born to mothers with HIV
The normal range for HIV-1 RNA levels varies depending on the stage of infection and treatment. Abnormal results may indicate a higher viral load, which can affect treatment decisions. Your doctor will interpret the results in context with your medical history and other tests.
During the test:
- A small sample of your blood and plasma will be collected using a needle.
- The collection process is typically quick and may cause mild discomfort.
- The samples will be sent to the laboratory for analysis.
- The test uses flow cytometry and real-time PCR methods to measure the HIV-1 RNA levels.
- Results are usually available the next day.
To prepare for the test:
- No fasting or special diet is required.
- Inform your healthcare provider about any medications you are taking.
- Follow any specific instructions given by your doctor regarding the timing of medication doses.
Provide accurate clinical history, including previous HIV tests and treatment information.
Other tests that may be recommended alongside HIV-1 RNA Combo 1 include:
- CD4 count: Measures the number of CD4 cells in your blood to evaluate immune function
- Drug resistance testing: Determines if the virus has developed resistance to specific antiretroviral medications.
HIV viral load test or HIV RNA test
HIV/AIDS refers to Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS). HIV weakens the immune system, and if left untreated, it can progress to AIDS, a stage where the immune system is severely damaged, making individuals susceptible to opportunistic infections and other illnesses.
The HIV combo test is a diagnostic tool that detects both antibodies and the p24 antigen of HIV-1 and HIV-2. It aids in the early detection and diagnosis of HIV infections, even before the body develops antibodies.
Yes, home sample collection for the HIV combo test is available through certain diagnostic centres like Metropolis Healthcare. These labs offer convenient home collection services, ensuring proper handling and timely transportation of the sample for accurate results. Always confirm availability with the specific laboratory.
For the HIV combo test, "normal" levels indicate that no HIV p24 antigen or antibodies to HIV-1 and HIV-2 are detected. The test provides a qualitative result, either reactive or non-reactive, rather than numerical values.
Currently, there is no cure for HIV infection. However, antiretroviral therapy (ART) can effectively manage the virus, suppressing viral loads to undetectable levels and preventing the progression to AIDS.
Symptoms of HIV infection can vary but may include flu-like symptoms in the early stages, such as fever, rash, and swollen lymph nodes. In later stages, symptoms can include weight loss, recurrent infections, and opportunistic infections.
HIV becomes AIDS (Acquired Immunodeficiency Syndrome) when the virus severely weakens the immune system, leading to a significant reduction in CD4 T cell count (typically below 200 cells/mm³) and the presence of specific opportunistic infections or cancers.
The window period is the time between exposure to HIV and when the test can detect the virus. For fourth-generation combo tests, this period is generally around 2-4 weeks, but it can be as short as 10-14 days in some cases.
The HIV combo test is used for early detection and diagnosis of HIV-1 and HIV-2 infections, screening to prevent transmission through blood and other bodily fluids, and in multi-test algorithms to confirm positive results.
The frequency of testing depends on individual risk factors. Those at high risk should get tested every 3-6 months. For others, annual testing may suffice.
There is no specific time of day recommended for the HIV combo test.
No, fasting is not required for the HIV combo test.
It is important to avoid any activities that could lead to cross-contamination and ensure that the sample is collected and handled properly. Follow the instructions provided by the healthcare professional or laboratory.
The HIV combo test measures the presence of HIV p24 antigen and antibodies to HIV-1 and HIV-2. The p24 antigen indicates an active HIV infection, while the antibodies indicate exposure to the virus and an immune response.
The HIV combo test should be done if you have recently engaged in high-risk behaviours, have been exposed to HIV, or as part of routine screening.
Generally, the test itself can be completed within a few hours, but results may take a few days to be available.
The turnaround time for HIV combo test reports can vary depending from lab to lab and their workload. Typically, results are available within 24 hours based on day/time the sample was collected and processed.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

WhatsApp